Correlation Between Bausch Health and Immunome

Can any of the company-specific risk be diversified away by investing in both Bausch Health and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bausch Health Companies and Immunome, you can compare the effects of market volatilities on Bausch Health and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Immunome.

Diversification Opportunities for Bausch Health and Immunome

0.23

Correlation Coefficient

Bausch Health  Immunome

Modest diversification

The 3 months correlation between Bausch and Immunome is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Bausch Health i.e., Bausch Health and Immunome go up and down completely randomly.

Pair Corralation between Bausch Health and Immunome

Considering the 90-day investment horizon Bausch Health Companies is expected to generate 0.61 times more return on investment than Immunome. However, Bausch Health Companies is 1.63 times less risky than Immunome. It trades about -0.06 of its potential returns per unit of risk. Immunome is currently generating about -0.11 per unit of risk. If you would invest  773.00  in Bausch Health Companies on December 29, 2024 and sell it today you would lose (98.00) from holding Bausch Health Companies or give up 12.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bausch Health Companies  vs.  Immunome

Bausch Health Companies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bausch Health Companies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Immunome

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Bausch Health and Immunome

The main advantage of trading using opposite Bausch Health and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.

The idea behind Bausch Health Companies and Immunome pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.